184 related articles for article (PubMed ID: 37648814)
21. Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27).
McCabe MT; Graves AP; Ganji G; Diaz E; Halsey WS; Jiang Y; Smitheman KN; Ott HM; Pappalardi MB; Allen KE; Chen SB; Della Pietra A; Dul E; Hughes AM; Gilbert SA; Thrall SH; Tummino PJ; Kruger RG; Brandt M; Schwartz B; Creasy CL
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2989-94. PubMed ID: 22323599
[TBL] [Abstract][Full Text] [Related]
22. Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression.
Mottok A; Woolcock B; Chan FC; Tong KM; Chong L; Farinha P; Telenius A; Chavez E; Ramchandani S; Drake M; Boyle M; Ben-Neriah S; Scott DW; Rimsza LM; Siebert R; Gascoyne RD; Steidl C
Cell Rep; 2015 Nov; 13(7):1418-1431. PubMed ID: 26549456
[TBL] [Abstract][Full Text] [Related]
23. CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis.
Huang YH; Cai K; Xu PP; Wang L; Huang CX; Fang Y; Cheng S; Sun XJ; Liu F; Huang JY; Ji MM; Zhao WL
Signal Transduct Target Ther; 2021 Jan; 6(1):10. PubMed ID: 33431788
[TBL] [Abstract][Full Text] [Related]
24. Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma.
Karkhanis V; Alinari L; Ozer HG; Chung J; Zhang X; Sif S; Baiocchi RA
J Biol Chem; 2020 Jan; 295(5):1165-1180. PubMed ID: 31822509
[TBL] [Abstract][Full Text] [Related]
25. The enzymes LSD1 and Set1A cooperate with the viral protein HBx to establish an active hepatitis B viral chromatin state.
Alarcon V; Hernández S; Rubio L; Alvarez F; Flores Y; Varas-Godoy M; De Ferrari GV; Kann M; Villanueva RA; Loyola A
Sci Rep; 2016 May; 6():25901. PubMed ID: 27174370
[TBL] [Abstract][Full Text] [Related]
26. GATA3-driven expression of miR-503 inhibits prostate cancer progression by repressing ZNF217 expression.
Jiang X; Chen Y; Du E; Yang K; Zhang Z; Qi S; Xu Y
Cell Signal; 2016 Sep; 28(9):1216-1224. PubMed ID: 27267060
[TBL] [Abstract][Full Text] [Related]
27. Implication of
Smeester BA; Draper GM; Slipek NJ; Larsson AT; Stratton N; Pomeroy EJ; Becklin KL; Yamamoto K; Williams KB; Laoharawee K; Peterson JJ; Abrahante JE; Rathe SK; Mills LJ; Crosby MR; Hudson WA; Rahrmann EP; Largaespada DA; Moriarity BS
Mol Cancer Ther; 2020 Dec; 19(12):2528-2541. PubMed ID: 32999043
[TBL] [Abstract][Full Text] [Related]
28. The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression.
Littlepage LE; Adler AS; Kouros-Mehr H; Huang G; Chou J; Krig SR; Griffith OL; Korkola JE; Qu K; Lawson DA; Xue Q; Sternlicht MD; Dijkgraaf GJ; Yaswen P; Rugo HS; Sweeney CA; Collins CC; Gray JW; Chang HY; Werb Z
Cancer Discov; 2012 Jul; 2(7):638-51. PubMed ID: 22728437
[TBL] [Abstract][Full Text] [Related]
29. Direct binding of CoREST1 to SUMO-2/3 contributes to gene-specific repression by the LSD1/CoREST1/HDAC complex.
Ouyang J; Shi Y; Valin A; Xuan Y; Gill G
Mol Cell; 2009 Apr; 34(2):145-54. PubMed ID: 19394292
[TBL] [Abstract][Full Text] [Related]
30. Ectopic expression of homeobox gene NKX2-1 in diffuse large B-cell lymphoma is mediated by aberrant chromatin modifications.
Nagel S; Ehrentraut S; Tomasch J; Quentmeier H; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
PLoS One; 2013; 8(4):e61447. PubMed ID: 23637834
[TBL] [Abstract][Full Text] [Related]
31. The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone.
Bellanger A; Donini CF; Vendrell JA; Lavaud J; Machuca-Gayet I; Ruel M; Vollaire J; Grisard E; Győrffy B; Bièche I; Peyruchaud O; Coll JL; Treilleux I; Maguer-Satta V; Josserand V; Cohen PA
J Pathol; 2017 May; 242(1):73-89. PubMed ID: 28207159
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
Zhang P; Zhang M
Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
[TBL] [Abstract][Full Text] [Related]
33. Specific recognition of ZNF217 and other zinc finger proteins at a surface groove of C-terminal binding proteins.
Quinlan KG; Nardini M; Verger A; Francescato P; Yaswen P; Corda D; Bolognesi M; Crossley M
Mol Cell Biol; 2006 Nov; 26(21):8159-72. PubMed ID: 16940172
[TBL] [Abstract][Full Text] [Related]
34. Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival.
Roberts RA; Wright G; Rosenwald AR; Jaramillo MA; Grogan TM; Miller TP; Frutiger Y; Chan WC; Gascoyne RD; Ott G; Muller-Hermelink HK; Staudt LM; Rimsza LM
Blood; 2006 Jul; 108(1):311-8. PubMed ID: 16543468
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors.
Mao XG; Yan M; Xue XY; Zhang X; Ren HG; Guo G; Wang P; Zhang W; Huo JL
Lab Invest; 2011 Jul; 91(7):1068-78. PubMed ID: 21483406
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-135 inhibits initiation of epithelial-mesenchymal transition in breast cancer by targeting ZNF217 and promoting m6A modification of NANOG.
Xu LM; Zhang J; Ma Y; Yuan YJ; Yu H; Wang J; Cao XC; Zhu L; Wang P
Oncogene; 2022 Mar; 41(12):1742-1751. PubMed ID: 35121826
[TBL] [Abstract][Full Text] [Related]
37. Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma.
Gunawardana J; Chan FC; Telenius A; Woolcock B; Kridel R; Tan KL; Ben-Neriah S; Mottok A; Lim RS; Boyle M; Rogic S; Rimsza LM; Guiter C; Leroy K; Gaulard P; Haioun C; Marra MA; Savage KJ; Connors JM; Shah SP; Gascoyne RD; Steidl C
Nat Genet; 2014 Apr; 46(4):329-35. PubMed ID: 24531327
[TBL] [Abstract][Full Text] [Related]
38. A functional interplay between ZNF217 and estrogen receptor alpha exists in luminal breast cancers.
Nguyen NT; Vendrell JA; Poulard C; Győrffy B; Goddard-Léon S; Bièche I; Corbo L; Le Romancer M; Bachelot T; Treilleux I; Cohen PA
Mol Oncol; 2014 Dec; 8(8):1441-57. PubMed ID: 24973012
[TBL] [Abstract][Full Text] [Related]
39. The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor Progression.
Fahmé P; Ramadan F; Le DT; Thi KN; Ghayad SE; Hussein N; Diaz C; Croset M; Clézardin P; Cohen PA
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551531
[TBL] [Abstract][Full Text] [Related]
40. TGF-β-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex.
Thillainadesan G; Chitilian JM; Isovic M; Ablack JN; Mymryk JS; Tini M; Torchia J
Mol Cell; 2012 Jun; 46(5):636-49. PubMed ID: 22560925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
